HOME >> MEDICINE >> NEWS
Implanted wireless device alerts patients and physicians to dangerous conditions

What if a doctor could keep tabs on a patient's heart failure symptoms on a daily basis, detect-ing subtle increases in weight and blood pressure, the tell-tale signs of worsening heart fail-ure, and summoning the patient to the hospital before they themselves were aware that any-thing was wrong?

More than half a million Americans are diagnosed with heart failure each year, and the condition causes or contributes to 300,000 deaths annually. In addition to being one of the leading causes of death in the U.S., heart failure is the number one cause of hospitalization for people aged 65 and older, it is the most expensive medical condition in the U.S., and its incidence is growing because of the aging population.

Many heart failure patients receive an implanted cardiac resynchronization therapy defibrillator (CRT-D) device upon diagnosis. Now, wireless technology can monitor these devices, along with blood pressure and weight, on a daily basis. The wireless system offers doctors a significant opportunity to better treat heart failure, keep patients out of the hospital and bring them greater peace of mind.

Using Bluetooth technology, Boston Scientific's LATITUDE Patient Management System allows doctors to remotely monitor specific information about the patients' condition to determine if the heart is showing signs of decline. If information is transmitted that suggests something is wrong, the patient's physician can intervene. LATITUDE is the only FDA-approved product for wireless home monitor-ing of a patient's heart condition, implanted device, blood pressure and weight. This wireless cardiac rhythm management system is very new, and many consumers don't realize how important daily monitoring of weight and blood pressure is to detecting early warning signs of worsening heart failure.

Is this something you might be interested in hearing more about? I can arrange interviews for you with cardiologists and patients using this tec
'"/>

Contact: Bill Gray
btgray@webershandwick.com
952-346-6226
Weber Shandwick Worldwide
18-Sep-2006


Page: 1 2

Related medicine news :

1. Implanted medical device aims to lower blood pressure
2. Doctors, engineers develop new wireless system to detect esophageal reflux
3. SCAI highlights study using wireless technology to speed care of heart attack patients
4. New long-distance wireless networking developed at UC Berkeley brings eye care to India
5. Chinese children with hearing devices benefit from new speech test
6. Miniature implanted devices could treat epilepsy, glaucoma
7. Home health care devices focus of FDA Conference at UH
8. Innovative device to treat brain cancer shows promise in early studies
9. New device for stroke patients improves walking
10. UPMC begins study of heart support device as a bridge to transplantation
11. Smokeless cannabis delivery device efficient and less toxic

Post Your Comments:
(Date:11/27/2014)... 2014 HealthPostures, a leading ... , has announced that it has entered into ... The partnership will put HealthPostures' products into central ... In addition to having its products sold through ... HealthPostures' products with the business decision makers in ...
(Date:11/27/2014)... Philadelphia, PA (PRWEB) November 27, 2014 ... alongside volunteer Aria Health employees, prepared and donated ... to the Lutheran Settlement House , a non-profit, ... and families living in Philadelphia. The dinners were ... Settlement House Senior Center, and distributed to vulnerable ...
(Date:11/27/2014)... November 27, 2014 Allowing children to help ... during school, helps give children responsibility, ownership, boosts self-esteem, and ... , Now, the real question is, how do you ... secret? According to a study published by Child Development Journal, ... a dramatic effect on a child’s willingness to lend a ...
(Date:11/27/2014)... 27, 2014 At The Little Gym, ... it came as no surprise when a recent study ... academic success. The Journal of Pediatrics found ... motor tasks during the school years may be important ... development.” The study monitored two groups of children; those ...
(Date:11/27/2014)... "The uglier, the better," says Dr. Kirk Kimmerling. "Every ... as we enjoy the ugly sweater contest." Last year's ... " It was a sight to see. She glued ... the Christmas balls were faces of the staff with Dr. ... this year, it's simple to get in on the fun. ...
Breaking Medicine News(10 mins):Health News:Ergonomics Manufacturer Announces New Partnership with Office Supply Dealer 2Health News:Aria Health Prepares and Donates 200 Thanksgiving Dinners 2Health News:Verde Pointe Dental Associates Hosts 2014 Ugly Holiday Sweater Contest 2Health News:Verde Pointe Dental Associates Hosts 2014 Ugly Holiday Sweater Contest 3
(Date:11/26/2014)... 26, 2014  Cohen, Placitella & Roth, PC ... who purchased Nymox Pharmaceutical Corporation ("Nymox" or "Company") ... from January 31, 2011 through November 2, 2014 ... certain of its officers and directors publically disseminated ... Sections 10(b) and 20(a) of the Securities Exchange ...
(Date:11/26/2014)... , Nov. 26, 2014  Avanir Pharmaceuticals, Inc. (NASDAQ: ... U.S. Food and Drug Administration (FDA) has issued ... Application (NDA) for AVP-825. AVP-825 is an investigational ... delivered intranasally utilizing a novel Breath Powered delivery ... letter, and consistent with the preliminary feedback announced ...
(Date:11/26/2014)... , Nov. 26, 2014  BioScrip ® , Inc. (NASDAQ: ... , President and Chief Executive Officer, will present at the Bank ... , , , Date: , , , Wednesday, December ... 2:50 p.m. EST , , , , Location: , , ... About BioScrip, Inc. BioScrip, Inc. ...
Breaking Medicine Technology:Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 2Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 3Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 2Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 3Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 4
Cached News: